FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109) By linking statewide hospital discharge ...
On the heels of warnings from the U.S. Food and Drug Administration about the risks of using power morcellators in uterine surgery, the Judicial Panel on Multidistrict Litigation has been asked to ...
US regulators today announced major restrictions on laparoscopic power morcellator (LPM) devices following major concerns that the devices could be harming patients. The restrictions, announced on 24 ...
The Government Accountability Office (GAO) on Wednesday released the results of its year-and-a-half long investigation into the US Food and Drug Administration's (FDA) handling of laparoscopic power ...
CENTER VALLEY, Pa., Nov. 30, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today the market ...
As concerns surrounding the use of power morcellators (http://www.injurybeacon.com/power-morcellator/) in gynecological surgeries continue to grow, Bernstein Liebhard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results